David Lebwohl - EVP, Chief Medical Officer at Intellia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Medical Officer
Stock Symbol
NTLA on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
All Insider Reports
All Insider Reports

David Lebwohl - trading volume in the past year for Intellia Therapeutics, Inc.

Holdings reported by David Lebwohl for Intellia Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 93.1K $2.73M $29.38 Mar 1, 2024 Direct
Restricted Stock Unit 3.19K $76.2K $23.90 Jan 1, 2024 Direct Common Stock
Stock Option (right to buy) 55.9K Mar 1, 2024 Direct Common Stock

Transactions reported by David Lebwohl for Intellia Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.